Results 151 to 160 of about 26,995 (192)

Emergence of <i>tet</i>(X4)-positive <i>Klebsiella</i> isolates from aquatic products in Hainan, China. [PDF]

Antimicrob Agents Chemother
Wang Y, Wang Y, Zhai W, Chen W, Wang Y, Shen J, Sun C, Liu D.   +7 more
europepmc   +1 more source

Characterization of tmexCD-toprJ-positive Klebsiella spp. from pediatric patients in a Chinese hospital. [PDF]

BMC Microbiol
Jiang C, Zeng X, Zhang X, Huang L, Liu L, Li X, Liu Y, Dong N, Zhang S, Li Y.   +9 more
europepmc   +1 more source

Dose optimization of inhaled tigecycline in humans to overcome inherent adverse events and maximize bacterial clearance using a physiologically-based pharmacokinetic modeling approach. [PDF]

Front Tuberc
Park H, Singh A, Srivastava A, Thalluri B, Mathieu CJ, Gupta P, Pearce CM, Zohaib Ali M, Alshiraihi IM, Maloney Norcross SE, Hickey AJ, Gonzalez-Juarrero M, Meibohm B.   +12 more
europepmc   +1 more source

Bacterial distribution and drug resistance patterns of urinary tract infection in tuberculosis patients: a 5-year retrospective study. [PDF]

Front Microbiol
Shui J, Tan A, Pan J, Shi G.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Tigecycline: an update

Diagnostic Microbiology and Infectious Disease, 2013
Tigecycline is a broad-spectrum antibiotic with activity against difficult-to-treat pathogens such as methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus spp., Acinetobacter baumannii, and Gram-negative bacterial strains that produce extended-spectrum β-lactamases.
Gary E Stein, Timothy Babinchak
exaly   +3 more sources